Milestones in normal tissue radiation biology over the past 50 years: From clonogenic cell survival to cytokine networks and back to stem cell recovery

International Journal of Radiation Biology

Volumn 85, Issue 7, 2009, Pages 574-586

  Stewart, Fiona A ^a   Dörr, Wolfgang ^b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Biologically targeted therapies; Clonogenic survival; Fractionation and overall treatment time; Normal tissues; Pathogenesis

Indexed keywords

ACADEMIC ACHIEVEMENT; ALGORITHM; CELL KINETICS; CELL PROLIFERATION; CLONOGENESIS; CYTOKINE PRODUCTION; HUMAN; IMMUNOMODULATION; MEDICAL RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOBIOLOGY; RADIOSENSITIVITY; REVIEW; STEM CELL TRANSPLANTATION; THEORY;

ANIMALS; CELL SURVIVAL; CYTOKINES; HUMANS; MODELS, BIOLOGICAL; RADIATION TOLERANCE; RADIOBIOLOGY; RECEPTOR, EPIDERMAL GROWTH FACTOR; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 67651146520     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000902985136     Document Type: Review

References (107)

1. Ang KK, Jiang GL, Feng Y, Stephens LC, Tucker SL, Price RE. 2001. Extent and kinetics of recovery of occult spinal cord injury. International Journal of Radiation Oncology Biology and Physics 50:1013-1020.
2. Ang KK, Price RE, Stephens LC, Jiang GL, Feng Y, Schultheiss TE, Peters LJ. 1993. The tolerance of primate spinal cord to re-irradiation. International Journal of Radiation Oncology Biology and Physics 25:459-464.
3. Ang KK, Van der Kogel AJ, Van der Schueren E. 1983. The effect of small radiation doses on the rat spinal cord: The concept of partial tolerance. International Journal of Radiation Oncology Biology and Physics 9:1487-1491.
4. Ang KK, Xu FX, Vanuytsel L, Van der Schueren E. 1985. Repopulation kinetics in irradiated mouse lip mucosa: The relative importance of treatment protraction and time distribution of irradiations. Radiation Research 101:162-160.
5. Barendsen GW. 1982. Dose fractionation dose rate, and isoeffect relationships for normal tissue responses. International Journal of Radiation Oncology Biology and Physics 8:1981-1987.
6. Baumann M, Krause M, Dikomey E, Dittmann K, Dörr W, Kasten-Pisula U, Rodemann H-P. 2007. EGFR-targeted anti-cancer drugs in radiotherapy: Preclinical evaluation of mechanisms. Radiotherapy and Oncology 83:238-248.
7. Bentzen SM. 2006. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nature Reviews in Cancer 6:702-713.
8. Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P. European Organisation for Research and Treatment of Cancer (EORTC). 2007. Taskforce for the Elderly. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Update. European Journal of Cancer 43:258-270.
9. Brown M. 2008. What causes the radiation gastrointestinal syndrome? Overview. International Journal of Radiation Oncology Biology and Physics 70:799-800.
10. Coggle JE. 1987. Proliferation of type II pneumonocytes after X-irradiation. International Journal of Radiation Biology 51:393-399.
11. Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. 2003. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. Journal of Clinical Oncology 21:2545-2550.
12. Denekamp J. 1973. Changes in the rate of repopulation during multifraction irradiation of mouse skin. British Journal of Radiology 46:381-387.
13. Cieciura SJ, Marcus PI, Puck TT. 1956. Clonal growth in vitro of epithelial cells from normal human tissues. Journal of Experimental Medicine 104:615-628.
14. Dörr W. 1994. Repopulation in mouse oral mucosa: Treatment splits. Radiotherapy and Oncology 33:139-147.
15. Dörr W. 2000. Radiation-induced changes in expression of EGF and EGF-R in mouse tongue epithelium. Molecular Radiation Biology/Oncology 1:57.
16. Dörr W. 2003a. Oral mucosa: Response modification by keratinocyte growth factor. In: Nieder C, Milas L, Ang KK, editors. Biological modification of radiation response. Berlin-Heidelberg-New York: Springer. pp 113-122.
17. Dörr W. 2003b. Modulation of response processes in oral mucosa: Experimental results. International Journal of Radiation Biology 79:531-537.
18. Dörr W. 2009a. Time factors in normal tissues responses to irradiation. In: Joiner M, Van der Kogel A,editors. Basic clinical radiobiology. 4th ed., Oxford: Oxford University Press/ Hodder Arnold. Chapter 11, 149-157.
19. Dörr W. 2009b. Pathogenesis of normal tissue side effects. In: Joiner M, Van der Kogel A,editors. Basic clinical radiobiology. 4th ed., Oxford: Oxford University Press/Hodder Arnold. Chapter 13, 169-190.
20. Dörr W. 2009c. Biological response modifiers: Normal tissues. In: Joiner M, Van der Kogel A,editors. Basic clinical radiobiology. 4th ed., Oxford: Oxford University Press/Hodder Arnold. Chapter 22, 301-315.
21. Dörr W, Bässler S, Reichel S, Spekl K. 2005a. Reduction of radiochemotherapy-induced early oral mucositis by recombi-nant human Keratinocyte Growth Factor (KGF): Experimental studies in mice. International Journal of Radiation Oncology Biology and Physics 62:881-887.
22. Dörr W, Gabriel P, Kuschel M, Pickert A, Siegemund A. 2006a. Mobilization of bone marrow stem cells modulates oral mucositis (mouse) during fractionated irradiation. Nova Acta Leopoldina 95:111.
23. Dörr W, Heider K, Spekl K. 2005b. Reduction of oral mucositis by palifermin (rHuKGF): Dose effect of rHuKGF. International Journal of Radiation Biology 81:557-565.
24. Dörr W, Hendry JH. 2001. Consequential late effects in normal tissues. Radiotherapy and Oncology 61:223-231.
25. Dörr W, Herrmann T. 2003. Pathogenetic mechanisms of lung fibrosis. In: Nieder C, Milas L, Ang KK, editors. Biological modification of radiation response, Berlin-Heidelberg-New York: Springer. pp 29-36.
26. Dörr W, Kummermehr J. 1990. Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiotherapy and Oncology 17: 249-259.
27. Dörr W, Noack R, Spekl K, Farrell CL. 2001. Modification of oral mucositis by keratinocyte growth factor: Single radiation exposure. International Journal of Radiation Biology 77: 341-347.
28. Dörr W, Reichel S, Spekl K. 2005c. Effects of Keratinocyte Growth Factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiotherapy and Oncology 75:99-105.
29. Dörr W, Riesenbeck D, Nieder C. 2006b. Early and late treatment-induced toxicity. In: Brown JM, Mehta MP, Nieder C, editors. Multimodal concepts for integration of cytotoxic drugs and radiation therapy. Berlin-Heidelberg-New York: Springer. pp 317-332.
30. Dörr W, Stewart FA. 2009. Retreatment tolerance of normal tissues. In: Joiner M, Van der Kogel A,editors. Basic clinical radiobiology. 4th ed., Oxford: Oxford University Press/Hodder Arnold. Chapter 19, 259-270.
31. Dörr W, Weber-Frisch M. 1995a. Effects of changing weekly dose on accelerated repopulation during fractionated irradiation of mouse tongue mucosa. International Journal of Radiation Biology 67:577-585.
32. Dörr W, Weber-Frisch M. 1995b. Repopulation response of mouse oral mucosa during unconventional fractionation protocols. Radiotherapy and Oncology 37:230-236.
33. Douglas BG, Fowler JF. 1976. The effect of multiple small doses of X-rays on skin reactions in the mouse and a basic interpretation. Radiation Research 66:401-426.
34. Ellis F. 1969. Dose time and fractionation: A clinical hypothesis. Clinical Radiology 20:1-7.
35. Elkind MM, Sutton H. 1959. X-ray damage and recovery in mammalian cells in culture. Nature 184:1292-1295.
36. Elkind MM, Sutton H. 1960. Radiation response of mammalian cells grown in culture. I Repair of X-ray damage in surviving Chinese hamster ovary cells. Radiation Research 13:556-593.
37. Fajardo LF, Berthrong M, Anderson RE. 2001. Radiation pathology, New York: Oxford University Press, Inc.
38. Fehrmann A, Dörr W. 2005. Effect of EGFR-inhibition on the radiation response of oral mucosa - experimental studies in mouse tongue epithelium. International Journal of Radiation Biology 81:437-443.
39. Field SB, Hornsey S. 1974. Damage to mouse lung with neutrons and X-rays. British Journal of Cancer 10:621-627.
40. Fletcher GH, MacComb WS, Shalek RJ. 1962. In: Radiation therapy in the management of cancer of the oral cavity and oropharynx. In: Springfield, IL: Charles Thomas.
41. Fowler JF, Morgan MA, Sylvester JA, Bewley DK, Turner BA. 1963. Experiments with fractionated X-ray treatment of the skin of pigs. I. Fractionation up to 28 days. British Journal of Radiology 36:88-196.
42. François S, Mouiseddine M, Mathieu N, Semont A, Monti P, Dudoignon N, Saché A, Boutarfa A, Thierry D, Gourmelon P, Chapel A. 2007. Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model. Annals of Hematology 86:1-8.
43. Ganser A, Karthaus M. 1996. Clinical use of hematopoietic growth factors. Current Opinion in Oncology 8:265-269.
44. Gothard L, Cornes P, Brooker S, Earl J, Glees J, Hall E, Peckitt C, Tait D, Yarnold J. 2005. Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. Radiotherapy and Oncology 75:334-341.
45. Gothard L, Cornes P, Earl J, Hall E, MacLaren J, Mortimer P, Peacock J, Peckitt C, Woods M, Yarnold J. 2004. Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. Radiotherapy and Oncology 73:133-139.
46. Gould MN, Clifton KH. 1977. The survival of mammary cells following irradiation in vivo: A directly generated single-dose-survival curve. Radiation Research 72:343-352.
47. Haagen J, Schmidt M, Siegemund A, Noack R, Dörr W. 2008. Modification of radiation-induced oral mucositis (mouse) by treatment with adult mesenchymal stem cells Radiotherapy and Oncology 88(Suppl. 2):S92(Abstr. 286).
48. Hakenjos L, Bamberg M, Rodemann HP. 2000. TGF-beta1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. International Journal of Radiation Biology 76:503-509.
49. Hallahan D, Kuchibhotla J, Wyble C. 1996. Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium. Cancer Research 56:5150-5155.
50. Hendry JH. 1984. Correlation of the dose-response relationships for epidermal colony-forming units, skin reactions and healing, in the X-irradiated mouse tail. British Journal of Radiology 57:909-918.
51. Hendry JH, Dörr W, Hill RP, Potten CS. 2008. No apoptotic endothelial cells in irradiated intestine: In regards to Schuller et al. (International Journal of Radiation Oncology Biology and Physics 2007;68:205-210). International Journal of Radiation Oncology Biology and Physics 70:801-802.
52. Hendry JH, Moore JV. 1985. Deriving absolute values of α and β for dose fractionation, suing dose-incidence data. British Journal of Radiology 58:885-890.
53. Hendry JH, Potten CS, Roberts NP. 1983. The gastrointestinal syndrome and mucosal clonogenis cells: Relationships between target cell sensitivities, LD50 and cell survival, and their modification by antibiotics. Radiation Research 96:100-112.
54. Henke M, Allonsi M, Foa P, Giralt J, Bardet E, Cerezo L, Salzwimmer M, Whiley M, Emmerson L, Berger D. 2008. Palifermin significantly reduces severe oral mucositis in subjects with resected locally advanced head and neck cancer undergoing postoperative concurrent radio-chemotherapy. Radiotherapy and Oncology 88(Suppl. 2):S152(Abstr. 460).
55. Herskind C, Rodemann HP. 2000. Spontaneous and radiation-induced differentiation of fibroblasts. Experimental Gerontology 35:747-755.
56. Hopewell JW, Nyman J, Turesson I. 2003. Time factor for acute tissue reactions following fractionated irradiation: A balance between repopulation and enhanced radiosensitivity. International Journal of Radiation Biology 79:513-524.
57. Hornsey S. 1973. The effectiveness of fast neutrons compared with low LET radiation on cell survival measured in the mouse jejunum. Radiation Research 55:58-68.
58. Hornsey S, Myers R, Coultas PG, Rogers MA, White A. 1981. Turnover of proliferative cells in the spinal cord after X irradiation and its relation to time-dependent repair of radiation damage. British Journal of Radiology 54:1081-1085.
59. Hornsey S, Myers R, Warren P. 1982. Residual injury in the spinal cord after treatment with X-rays or neutrons. British Journal of Radiology 55:516-519.
60. Lombaert IM, Brunsting JF, Wierenga PK, Faber H, Stokman MA, Kok T, Visser WH, Kampinga HH,
61. de Haan G, Coppes RP. 2008. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS ONE 3:e2063.
62. Lombaert IM, Wierenga PK, Kok T, Kampinga HH, deHaan G, Coppes RP. 2006. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clinical Cancer Research 12:1804-1812.
63. Joiner MC, Bentzen SM. 2008. Fractionation: The linear-quadratic approach. In: Joiner M, Van der Kogel A,editors. Basic clinical radiobiology. 4th ed., Oxford: Oxford University Press/Hodder Arnold. Chapter 8, accepted.
64. Michalowski A. 1981. Effects of radiation on normal tissues: hypothetical mechanisms of limitations of in situ assays of clonogenicity. Radiation Environmental Biophysics 19:157-172.
65. Molteni A, Moulder JE, Cohen EF, Ward WF, Fish BL, Taylor JM, Wolfe LF, Brizio-Molteni L, Veno P. 2000. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angioten-sin II type 1 receptor blocker. International Journal of Radiation Biology 76:523-532.
66. Moulder JE, Fish BL, Cohen EP. 2007. Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists. Current Pharmaceutical Design 13: 1317-1325.
67. Mulcahy RT, Gould MN, Clifton KH. 1980. The survival of thyroid cells: In vivo irradiation and in situ repair. Radiation Research 84:523-528.
68. Nieder C, Jeremec B, Licht T, Zimmermann FB. 2003. Hematopoietic tissue II: Role of colony-stimulating factors. In: Nieder C, Milas L, Ang KK, editors. Biological modification of radiation response. Berlin-Heidelberg-New York: Springer. pp 103-112.
69. Nieder C, Schnaiter A, Weber WA, Schill S, Andratschke N, Schwaiger M, Molls M. 2007. Detrimental effects of an antibody directed against tumor necrosis factor alpha in experimental kidney irradiation. Anticancer Research 27:2353-2357.
70. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C, Kolesnick R. 2001. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293:293-297.
71. Puck TT, Marcus PI. 1955. A rapid method for viable cell titration and clone production with Hela cells in tissue culture: The use of X-irradiated cells to supply conditioning factors. Proceedings of the National Academy of Science of the USA 41:432-437.
72. Puck TT, Morkovind D, Marcus PI, Cieciura SJ. 1957. Action of X-rays on mammalian cells. II. Survival curves of cells from normal human tissues. Journal of Experimental Medicine 106: 485-500.
73. Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, Yang Z, Devitt ML, Horan GS, Weinreb PH, Lukashev ME, Violette SM, Grant KS, Colarossi C, Formenti SC, Munger JS. 2008. Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. American Journal of Respiratory and Critical Care Medicine 177:82-90.
74. Richter C, Jaal J, Kuschel M, Dörr W. 2007. Recombinant human keratinocyte growth factor modulates inflammatory changes in mouse oral mucosa during fractionated irradiation. International Journal of Radiation Oncology Biology and Physics 69(Suppl.):S603(Abstr. 2727).
75. Rodemann HP, Bamberg M. 1995. Cellular basis of radiation-induced fibrosis. Radiotherapy and Oncology 35:83-90.
76. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. 1995. A perpetual cascade of cytokines post irradiation leads to pulmonary fibrosis. International Journal of Radiation Oncology Biology and Physics 33:99-109.
77. Schultz-Hector S. 1992. Radiation-induced heart disease: Review of experimental data on dose response and pathogenesis. International Journal of Radiation Biology 61:149-160.
78. Sémont A, François S, Mouiseddine M, François A, Saché A, Frick J, Thierry D, Chapel A. 2006. Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Advances in Experimental Medicine and Biology 585:19-30.
79. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C. 2004. Palifermin for oral mucositis after intensive therapy for hematologic cancers. New England Journal of Medicine 351:2590-2598.
80. Stewart FA. 1985. The proliferative and functional response of mouse bladder to treatment with radiation and cyclophosphamide. Radiotherapy and Oncology 4:353-362.
81. Stewart FA. 1986. Mechanisms of bladder damage and repair after treatment with radiation and cytostatic drugs. British Journal of Cancer 53(Suppl. VII):280-291.
82. Stewart FA, Lebesque JV, Hart AAM. 1988. Progressive development of radiation damage in mouse kidneys and the consequences for re-irradiation tolerance. International Journal of Radiation Biology 53:405-415.
83. Stewart FA, Oussoren Y, Luts A. 1990. Long-term recovery and re-irradiation tolerance of mouse bladder. International Journal of Radiation Oncology Biology and Physics 18:1399-1406.
84. Stewart FA, Oussoren Y, Van Tinteren H, Bentzen SM. 1994. Loss of re-irradiation tolerance in the kidney with increasing time after single or fractionated partial tolerance doses. International Journal of Radiation Biology 66:169-179.
85. Stewart FA, Randhawa VS, Michael BD. 1984a. Multifraction irradiation of mouse bladders. Radiotherapy and Oncology 2:131-140.
86. Stewart FA, Soranson JA, Alpen EL, Williams MV, Denekamp J. 1984b. Radiation-induced renal damage: The effects of hyperfractionation. Radiation Research 98:407-420.
87. Stewart FA, Te Poele JA, Van der Wal AF, Oussoren YG, Van Kleef EM, Kuin A, Verheij M, Dewit LG. 2001. Radiation nephropathy: The link between functional damage and vascular mediated inflammatory and thrombotic changes. Acta Oncologica 40:952-957.
88. Stuschke M, Thames HD. 1997. Hyperfractionated radiotherapy of human tumors: Overview of the randomized clinical trials. International Journal of Radiation Oncology Biology and Physics 37:259-267.
89. Terry NHA, Tucker SL, Travis EL. 1988. Residual radiation damage in murine lung assessed by pneumonitis. International Journal of Radiation Oncology Biology and Physics 14:929-938.
90. Thames HD. 1985. An 'incomplete-repair' model for survival after fractionated and continuous irradiations. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 47:319-339.
91. Thames HD, Hendry JH. 1987. Fractionation in radiotherapy, London: Taylor and Francis.
92. Thames HD, Withers HR, Peters LJ, Fletcher GH. 1982. Changes in early and late radiation responses with altered dose fractionation: Implications for dose survival relationships. International Journal of Radiation Oncology Biology and Physics 8:219-226.
93. Till JE, McCulloch EA. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research 14:213-222.
94. Travis EL, Parkins CS, Down JD, Fowler JF, Thames HD Jr. 1983. Repair in mouse lung between multiple small doses of X-rays. Radiation Research 94:326-339.
95. Turesson I. 1991. Characteristics of dose-response relationships for late radiation effects: An analysis of skin teleangiectasia and of head and neck morbidity. Radiotherapy and Oncology 20:149-158.
96. Van der Kogel AJ. 1979. Late effects of radiation on the spinal cord. PhD Thesis. University of Amsterdam, Radiobiological Institute for the Organization for Health Research TNO, Rijswijk, The Netherlands.
97. Van der Kogel AJ, Sissungh HA, Zoetlief J. 1982. Effects of X-rays and neutrons on repair and regeneration in the rat spinal cord. International Journal of Radiation Oncology Biology and Physics 8:2095-2097.
98. Verheij M, Koomen GC, van Mourik JA, Dewit L. 1994. Radiation reduces cyclooxygenase activity in cultured human endothelial cells at low doses. Prostaglandins 48:351-366.
99. Wang J, Zheng H, Ou X, Fink LM, Hauer-Jensen M. 2002. Deficiency of microvascular thrombomodulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: Possible link between endothelial dysfunction and chronic radiation fibrosis. American Journal of Pathology 160: 2063-2072.
100. Withers HR. 1967. The dose-survival relationship for irradiation of epithelial cells of mouse skin. British Journal of Radiology 40:87-94.
101. Withers HR, Elkind MM. 1968. Dose-survival characteristics of epithelial cells of mouse intestinal mucosa. Radiology 91:998-1000.
102. Withers HR, Elkind MM. 1969. Radiosensitivity and fractionation response of crypt cells of mouse jejunum. Radiation Research 38:598-613.
103. Withers HR, Mason KA. 1974. The kinetics of recovery in irradiated colonic mucosa of the mouse. Cancer 34:896-903.
104. Withers HR, Taylor JM, Maciejewski B. 1988. Treatment volume and tissue tolerance. International Journal of Radiation Oncology Biology and Physics 14:751-759.
105. Withers HR, Hunter N, Barkley HT Jr, Reid BO. 1974. Radiation survival and regeneration characteristics of spermatogenic stem cells of mouse testis. Radiation Research 57:88-103.
106. Withers HR, Mason KA, Thames HD Jr. 1986. Late radiation response of kidney assayed by tubule-cell survival. British Journal of Radiology 59:587-595.
107. Withers HR, Thames HD, Peters LJ. 1982. Differences in the fractionation response of acute and late responding tissues. In: Kärcher KH, Kogelnik HD, Reinartz G, editors. Progress in radio-oncology I. New York: Raven Press. pp 287-296.